I have never advocated for a buyout. The value of their portfolio of patents is staggering. I haven't sold a share since I started buying in 2019. I have plans to sell a little bit at $20, just to take my own money off the table, but I will empty my cash account and my IRA and try to hold on to as much of the rest of it as possible. In 5-years or so SP should be way over $500, at current float.
I might be guilty of rah-rah (blanket bragging), but my toothpaste, Gary, really?
I hope they go with partnerships and licensing, but that will take time to get full realization of it's market valuation. I see rapid appreciation for 2-3 years, then as it is applied outside of oncology, a parabolic rise at about year 4. after first RA approval. I also see a lot of large investors wanting to control something like this.